During the past decade, Dallas Diabetes Research Center conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 10 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 10 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dallas Diabetes Research Center" #1 sponsor was "Eli Lilly and Company" with 19 trials, followed by "Pfizer" with 4 trials sponsored, "AstraZeneca" with 2 trials sponsored, "InteKrin Therapeutics, Inc." with 2 trials sponsored and "Applied Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dallas Diabetes Research Center" #1 collaborator was "ICON Clinical Research" with 1 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator, "TIMI Study Group" with 1 trials as a collaborator and "Triangle Biostatistics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Dallas Diabetes Research Center" are "Obesity" (9 trials), "Type 2 Diabetes" (9 trials), "Overweight" (6 trials), "Type 2 Diabetes Mellitus" (4 trials) and "Diabetes" (3 trials). Many other conditions were trialed in "Dallas Diabetes Research Center" in a lesser frequency.

Most popular intervention types in "Dallas Diabetes Research Center" are "Drug" (34 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Tirzepatide" (10 trials), "Insulin Degludec" (4 trials), "Dulaglutide" (3 trials) and "Insulin Efsitora Alfa" (3 trials). Other intervention names were less common.

The vast majority of trials in "Dallas Diabetes Research Center" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Dallas Diabetes Research Center". undefined are not yet recruiting, 3 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Dallas Diabetes Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dallas Diabetes Research Center, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".